Lv4
468 积分 2023-12-12 加入
Efficacy and safety of infliximab in patients with autoimmune hepatitis
22天前
已完结
Recognizing and avoiding siRNA off-target effects for target identification and therapeutic application
2个月前
已完结
Comparative Efficacy of Treatment Regimens for Chronic Hepatitis D Virus Infection: A Systematic Review and Network Meta-Analysis
2个月前
已完结
Emerging Trends and Future Directions in the Development of Anti-hepatitis B Therapies: A Horizon Scanning Review
2个月前
已完结
Novel insights into chronic HBV infection
2个月前
已完结
Development and validation of a hepatitis B-specific health-related quality-of-life instrument: CLDQ-HBV
3个月前
已完结
SOLSTICE: tobevibart plus elebsiran for hepatitis D
4个月前
已完结
Update on the management of HDV infection: current events and perspectives
4个月前
已完结
Hepatitis B virus-associated coinfection and superinfection with delta agent: indistinguishable disease with different outcome
5个月前
已完结
Delta hepatitis: an update
5个月前
已完结
皖公网安备34019202002308
